Cirrhosis runs in the family, study says

September 10, 2007  
Filed under Liver

Mayo Clinic release – Mayo Clinic researchers have found that first-degree relatives (i.e., parents, siblings, children) of patients with primary biliary cirrhosis (PBC) are more likely to have the biomarker of the disease in their blood. Armed with this new information, physicians could screen and assess first-degree relatives of PBC patients with a simple blood test, enabling them to diagnose and treat more patients before the disease causes irreversible liver damage. These findings were published in this month’s issue of Hepatology. Read more

Popular herb inhibits hep B expression, hope for new drug

March 7, 2007  
Filed under Liver

huang qin, chinese medicine, hepatitis, wogoninCM NEWS – An active ingredient of a popular traditional Chinese medicine huang qin (Scutellaria radix, 黃芩) has been shown to curb expression of two antigens in the human body that are indicative of hepatitis B virus (HBV) infection. As such, the substance is now being reviewed to see if an anti-HBV drug could be derived.

A recent study by researchers at the department of physiology of China Pharmaceutical University, Nanjing, China tested the effectiveness of wogonin (han huang qin su, 漢黃芩素), the major active constituent of huang qin on its anti-hepatitis B virus functions. Read more

Ancient formula Qiongyugao may fight liver cancer

January 28, 2007  
Filed under Cancer, Liver

fu ling, liver cancer, qiongyugaoCM NEWS – An ancient Chinese herbal formula composed mainly of ginseng (人參), poria (fu ling, 茯苓) and rehmannia (di huang, 地黃) has been found to be able to slow down the growth of tumour of the liver and inhibit the expression of a special protein that appears to participate in the development of hepatocellular carcinoma, the most common form of primary liver cancers. Read more